Cytokinetics Inc. (CYTK) Tops Q1 EPS by 1c
Get Alerts CYTK Hot Sheet
Join SI Premium – FREE
Cytokinetics Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share